Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Revenue Disaggregation (Tables)

Revenue Disaggregation (Tables)

12 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of disaggregated revenue by source

Schedule of disaggregated revenue by source
		Year Ended March 31,
		2023				2022
Product
Human Care		$	9,426,000			$	9,010,000
Animal Care			2,500,000				3,169,000
Total Product Revenue			11,926,000				12,179,000
Service/Royalty			1,346,000				449,000
Total		$	13,272,000			$	12,628,000

Schedule of geographic sales

Schedule of geographic sales
		Year Ended March 31,
		2023				2022
United States		$	3,428,000			$	3,807,000
Europe			4,051,000				3,410,000
Asia			2,451,000				2,350,000
Latin America			2,383,000				2,095,000
Rest of the World			959,000				966,000
Total		$	13,272,000			$	12,628,000